Transcatheter Tricuspid Valve Intervention Risk Scores
JACC: Cardiovascular Interventions · 2026-03 · 19 (6) · 665-676
DOI: 10.1016/j.jcin.2025.12.020 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Max Potratz und 21 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for General and Interventional Cardiology/Angiology, Heart and Diabetes Center North Rhine-Westphalia, Herz- und Diabeteszentrum NRW, Ruhr-Uni…. Hauptthemen laut MEDLINE: Cardiac Catheterization, Cardiac Valve Annuloplasty, Decision Support Techniques, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Accurate risk stratification is crucial for patients undergoing transcatheter tricuspid valve intervention (TTVI). The performance of existing surgical and TTVI risk scores (TRI-SCORE, STS-TR [Society of Thoracic Surgeons Tricuspid Regurgitation], and TRIVALVE [International Multisite Transcatheter Tricuspid Valve Therapies Registry]) has not been comprehensively evaluated and compared in a contemporary, real-world cohort. OBJECTIVES: The aim of this study was to assess the discrimination and calibration of these scores in a large international multicenter population of patients undergoing TTVI. METHODS: This study population included 457 patients from 6 international centers who underwent TTVI (tricuspid transcatheter edge-to-edge repair, transcatheter tricuspid valve replacement, or transcatheter tricuspid annuloplasty) between 2019 and 2024. The performance of the TRIVALVE score was assessed for the 1-year endpoint of death and rehospitalization. The TRI-SCORE and STS-TR scores were assessed for in-hospital and 30-day mortality, respectively. Performance was evaluated using C statistics for discrimination and smoothed calibration plots for calibration. RESULTS: All 3 scores demonstrated limitations. The TRIVALVE score showed low discrimination (area under the curve: 0.609) and was well calibrated after its endpoint was refined to exclude non-cardiovascular-related hospitalizations. The surgically derived TRI-SCORE and STS-TR scores were miscalibrated and significantly overestimated mortality. The TRI-SCORE showed an observed-to-expected mortality ratio of 0.13 (95% CI: 0.07-0.23), and the STS-TR score had an observed-to-expected mortality ratio of 0.35 (95% CI: 0.19-0.60). CONCLUSIONS: The currently available TTVI risk scores derived from surgical or early TTVI cohorts may not be well suited for accurate risk assessment in contemporary TTVI. The surgical scores when applied to TTVI are miscalibrated, and the TRIVALVE score lacks discrimination. There is a need for the development of a contemporary dedicated TTVI risk model validated specifically for this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for General and Interventional Cardiology/Angiology, Heart and Diabetes Center North Rhine-Westphalia, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany; Herz- und Diabeteszentrum NR…
- Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department for Internal Medicine III, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Clinic for General and Interventional Cardiology/Angiology, Heart and Diabetes Center North Rhine-Westphalia, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
- Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany.
- Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Zitieren
APA
Potratz, M., Narang, A., Gerçek, M., Körber, M. I., Kassar, M., Friedrichs, K. P., Rudolph, T. K., Puthumana, J., Lee, L., Cremer, P. C., Rudolph, F., Baldridge, A. S., Meng, Z., Kirchner, J., El-Harake, L., Davidson, L. J., Geisler, T., Rassaf, T., Pfister, R., …, & Davidson, C. J. (2026). Transcatheter Tricuspid Valve Intervention Risk Scores. JACC: Cardiovascular Interventions, 19(6), 665-676. https://doi.org/10.1016/j.jcin.2025.12.020
Vancouver
Potratz M, Narang A, Gerçek M, Körber MI, Kassar M, Friedrichs KP, et al. Transcatheter Tricuspid Valve Intervention Risk Scores. JACC: Cardiovascular Interventions. 2026;19(6):665-676. doi:10.1016/j.jcin.2025.12.020
BibTeX
@article{Potratz2026,
author = {Potratz, Max and Narang, Akhil and Gerçek, Muhammed and Körber, M Isabel and Kassar, Mohammad and Friedrichs, Kai P and Rudolph, Tanja K and Puthumana, Jyothy and Lee, Linda and Cremer, Paul C and Rudolph, Felix and Baldridge, Abigail S and Meng, Zhiying and Kirchner, Johannes and El-Harake, Lamis and Davidson, Laura J and Geisler, Tobias and Rassaf, Tienush and Pfister, Roman and Praz, Fabien and Rudolph, Volker and Davidson, Charles J},
title = {Transcatheter Tricuspid Valve Intervention Risk Scores},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {6},
pages = {665--676},
doi = {10.1016/j.jcin.2025.12.020}
}
EUVIMED